VRTX
NASDAQStockVertex Pharmaceuticals Incorporated
$479.41-13.10 (-2.66%)
52-Week Range
$366.54
$513.76
Key Stats
Market Cap
121.8B
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.32
Volume
940.1K
Avg Volume
1.4M
Performance
1M
+6.24%
3M
+8.92%
6M
+25.22%
YTD
+8.90%
1Y
-0.61%
3Y
+67.78%
5Y
+124.17%
Price Chart
ETF Exposure
VRTX is held by 370 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| MNTL | Tema Neuroscience And Mental Health ETF | 10.33% |
| BBH | VanEck Biotech ETF | 9.87% |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 9.51% |
| IBB | iShares Biotechnology ETF | 9.38% |
| MSGR | Direxion mRNA ETF | 8.09% |
| BIB | ProShares - Ultra Nasdaq Biotechnology | 6.47% |
| KONG | Formidable Fortress ETF | 5.10% |
| LSGR | Natixis Loomis Sayles Focused Growth ETF | 4.52% |
| GNOM | Global X - Genomics & Biotechnology ETF | 4.26% |
| TBXU | Direxion Daily Biotech Top 5 Bull 2X ETF | 4.00% |
| IDNA | iShares Genomics Immunology and Healthcare ETF | 3.88% |
| FBT | First Trust NYSE Arca Biotechnology Index Fund | 3.84% |
| FTXH | First Trust Nasdaq Pharmaceuticals ETF | 3.74% |
| SYE | SPDR MFS Systematic Core Equity ETF | 3.52% |
| HRTS | Tema Cardiovascular and Metabolic ETF | 3.51% |
| SEIQ | SEI Enhanced U.S. Large Cap Quality Factor ETF | 3.41% |
| HELX | Franklin Genomic Advancements ETF | 3.30% |
| APXH | Two Roads Shared Trust - APEX HealthCare ETF | 3.06% |
| TECB | iShares U.S. Tech Breakthrough Multisector ETF | 3.03% |
| QNXT | iShares Nasdaq-100 ex Top 30 ETF | 2.91% |
| CGVV | Capital Group U.S. Large Value ETF | 2.77% |
| PINK | Simplify Health Care ETF | 2.64% |
| PBPH | Portfolio Building Block World Pharma and Biotech Index ETF | 2.62% |
| DRUP | GraniteShares Nasdaq Select Disruptors ETF | 2.55% |
| QQEW | First Trust Nasdaq-100 Select Equal Weight ETF | 2.39% |
| JDOC | JPMorgan Healthcare Leaders ETF | 2.33% |
| QMJ | Direxion S&P 500 High minus Low Quality ETF | 2.30% |
| XLV | State Street Health Care Select Sector SPDR ETF | 2.29% |
| IYH | iShares U.S. Healthcare ETF | 2.06% |
| CGGG | Capital Group U.S. Large Growth ETF | 2.01% |
| TOLL | Tema Durable Quality ETF | 1.99% |
| SDG | iShares MSCI Global Sustainable Development Goals ETF | 1.97% |
| FHLC | FIDELITY MSCI HEALTH CARE INDEX ETF | 1.96% |
| CGUS | Capital Group Core Equity ETF | 1.94% |
| QQXT | First Trust NASDAQ-100 Ex-Technology Sector Index Fund | 1.93% |
| RND | First Trust Bloomberg R&D Leaders ETF | 1.93% |
| CGGR | Capital Group Growth ETF | 1.90% |
| RSPH | Invesco S&P 500 Equal Weight Health Care ETF | 1.89% |
| RYH | Invesco S&P 500 Equal Weight Health Care ETF | 1.89% |
| VHT | Vanguard Health Care ETF | 1.84% |
| BMED | iShares Health Innovation Active ETF | 1.83% |
| FDWM | FIDELITY WOMENS LEADERSHIP ETF | 1.76% |
| LRGE | ClearBridge Large Cap Growth Select ETF | 1.75% |
| FFND | One Global ETF | 1.74% |
| RXL | ProShares - Ultra Health Care | 1.70% |
| BBP | Virtus Biotech ETF | 1.69% |
| IXJ | iShares Global Healthcare ETF | 1.61% |
| RFFC | ALPS Active Equity Opportunity ETF | 1.61% |
| BAD | B.A.D. ETF | 1.60% |
| ESMV | iShares ESG Optimized MSCI USA Min Vol Factor ETF | 1.57% |
Page 1 of 8Next
About VRTX ETF Exposure
Vertex Pharmaceuticals Incorporated (VRTX) is held by 370 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 121.8B, VRTX is a widely held institutional stock. The stock currently trades at $479.41. Investors can gain exposure to VRTX through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold VRTX, sorted by portfolio weight.